Date | Source | Headline |
---|---|---|
23rd Mar 2006 7:03 am | RNS | Preliminary Results |
21st Mar 2006 2:07 pm | RNS | Interest in Major Shares |
2nd Mar 2006 7:00 am | RNS | Notice of Results |
9th Feb 2006 1:05 pm | RNS | Hydromol Acquisition |
10th Jan 2006 7:00 am | RNS | Trading Statement |
12th Dec 2005 7:02 am | RNS | Biotech Investment Forum |
3rd Nov 2005 7:02 am | RNS | Interim Results |
3rd Nov 2005 7:00 am | RNS | Product Disposal |
11th Oct 2005 11:21 am | RNS | Results Notification |
30th Sep 2005 7:03 am | RNS | Misoprostol Symposium |
19th Sep 2005 7:02 am | RNS | Appointment |
1st Aug 2005 7:00 am | RNS | Notification of Shares |
29th Jul 2005 7:00 am | RNS | Distribution Agreement |
13th Jul 2005 10:11 am | RNS | Notification of Shares |
6th Jul 2005 7:00 am | RNS | Phase III Trials Approval |
24th Jun 2005 7:00 am | RNS | Notice of Interests in Shares |
21st Jun 2005 10:52 am | RNS | AGM Statement |
17th May 2005 7:00 am | RNS | Share Purchase |
16th May 2005 12:35 pm | RNS | Director Share Dealing |
12th May 2005 7:01 am | RNS | Preliminary Results |
11th May 2005 9:55 am | RNS | Share Purchase |
9th May 2005 7:00 am | RNS | Co-Promotion Agreement |
26th Apr 2005 7:02 am | RNS | Key Management Appointments |
30th Mar 2005 5:33 pm | RNS | Holding(s) in Company |
16th Mar 2005 7:00 am | RNS | Trading Statement |
28th Feb 2005 11:37 am | RNS | Director Shareholding |
11th Jan 2005 7:00 am | RNS | Clinical Trial Commences |